Skip to content

Global Health-Medanta jumps 3% on #39;buy#39; rating from Motilal Oswal

“The company#39;s growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix,” Motilal Oswal Financial Services said.

Read More

​ “The company#39;s growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix,” Motilal Oswal Financial Services said. “The company#39;s growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix,” Motilal Oswal Financial Services said.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish